Multiple Sclerosis in the Emirati Population: Onset Disease Characterization by MR Imaging

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_center">Percentage</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">&lt;3</td><td class="align_center">4% (2)</td></tr><tr><td class="align_left">3–5</td><td class="align_center">19% (9)</td></tr><tr><td class="align_left">6–9</td><td class="align_center">17% (8)</td></tr><tr><td class="align_left">7–9</td><td class="align_center">15% (7)</td></tr><tr><td class="align_left">&gt;12</td><td class="align_center">45% (21)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Periventricular zone (PVZ) dissemination in space.</div>

Multiple Sclerosis International

tab3

Table 3

Table 3: Multiple Sclerosis in the Emirati Population: Onset Disease Characterization by MR Imaging 